Drug Type Small molecule drug |
Synonyms BM 201 |
Target |
Action agonists |
Mechanism TLR7 agonists(Toll like receptor 7 agonists), TLR8 agonists(Toll like receptor 8 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | - | 07 Nov 2022 |
| Sarcoma | Phase 1 | China | - | |
| Solid tumor | IND Approval | China | 08 Jul 2022 |
Phase 1 | 17 | fnhtdqyqmj(cmxkllxotv) = qvzestbxqv pshywbpcnl (sqcqhbnagv ) View more | Positive | 06 Dec 2024 | |||
(For the injected lesions) | fnhtdqyqmj(cmxkllxotv) = vakjppzthz pshywbpcnl (sqcqhbnagv ) View more |





